Nuacht

Fierce Pharma3 uair an chloig
Fierce Pharma Asia—Pfizer's PD-1xVEGF bet; An Alzheimer's blood test approval; Samsung's biosim spinoff
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
Zacks Investment Research on MSN4 uair an chloig
Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
Novo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...